Elidah, a healthcare technology company known for developing FDA-cleared non-invasive, wearable treatments for urinary incontinence in women, has recently announced the completion of its Series A funding round. The company has successfully secured an undisclosed amount of investment, led by Blu Venture Investors and supported by contributions from Right Side Capital and Integral Private Wealth Advisors. This financial milestone is set to…
The following guest post was written by Dr. Karla Loken, DO OBGYN FACOOG, Chief Medical Officer of a women’s health company FEMSelect and Liz Weir, Chief Marketing Officer of LevLane Advertising. 2023 was a pivotal year for women as pop culture and feminism collided in ways that they never have before. It was the year that gave us the “Barbie” movie. It gifted…
Freya Biosciences, a clinical-stage biotech company, has raised $38M Series A funding to advance the development of innovative women’s reproductive immunotherapies. The funding round was led by Sofinnova Partners and OMX Ventures with participation from The Export and Investment Fund of Denmark, Angelini Ventures, Mike Jafar Family Office, CE-Ventures, Corundum Systems Biology, and Indaco Venture Partners. Freya Biosciences’ Series A comes on…
Pelvital has announced the expansion of its innovative incontinence treatment device, Flyte, into the Middle East. This move aims to address the prevalent issue of stress urinary incontinence among women in the region. Flyte, a non-invasive, intravaginal device, is designed for home use and focuses on strengthening pelvic floor muscles. The device, which has received FDA clearance, was developed through a collaboration…
Hinge Health, a provider of musculoskeletal pain solutions, has introduced enhancements to its Women’s Pelvic Health Program. The expansion includes guided breathing and meditation, along with the integration of Perifit‘s software-connected pelvic floor training device designed to track kegel exercises and offer real-time biofeedback on strengthening progress. Hinge Health’s Pelvic Health Program has gained popularity with over 15,000 participants. Results now show…
Caldera Medical, a Los Angeles-based medical device company has announced the completion of its acquisition of Atlantic Therapeutics, an Ireland-based medical device provider specializing in non-invasive pelvic floor strengthening and nerve-stimulating solutions. Caldera Medical specializes in products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse, Polyps, and Fibroids. The company is committed to improving the quality of life for women…
Jude is the UK-based bladder care company, catering to people in mid-life who desire an active and independent lifestyle. The company offers online and on-the-phone assessments, tailored medical essentials, and holistic treatment plans that include supplements, kegel exercise plans, and bladder retraining programs. The startup has now raised a $4.24M seed round led by Eka VC, Joyance, Samos VC, and with grant…
In a recently published article in the International Journal of Gynecology & Obstetrics (IJGO), FEMSelect announced positive results for their EnPlace system. The research was presented during the 2023 International Urogynecology Association 48th Annual Meeting in The Hague, Netherlands. FEMSelect’s EnPlace system offers a new, minimally invasive technique for addressing pelvic organ prolapse without the need for extensive surgery or mesh. The…
